Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 140


microrna expression signature of gastric cancer cells relative to normal gastric mucosa.

Yu BQ, Su LP, Li JF, Cai Q, Yan M, Chen XH, Yu YY, Gu QL, Zhu ZG, Liu BY.

Mol Med Rep. 2012 Oct;6(4):821-6. doi: 10.3892/mmr.2012.1006. Epub 2012 Jul 26.


Gastric adenocarcinoma has a unique microRNA signature not present in esophageal adenocarcinoma.

Chen Z, Saad R, Jia P, Peng D, Zhu S, Washington MK, Zhao Z, Xu Z, El-Rifai W.

Cancer. 2013 Jun 1;119(11):1985-93. doi: 10.1002/cncr.28002. Epub 2013 Mar 1.


Primary analysis and screening of microRNAs in gastric cancer side population cells.

Zhang HH, Gu GL, Zhang XY, Li FZ, Ding L, Fan Q, Wu R, Shi W, Wang XY, Chen L, Wei XM, Yuan XY.

World J Gastroenterol. 2015 Mar 28;21(12):3519-26. doi: 10.3748/wjg.v21.i12.3519.


Comparison of microRNA profiles of human periodontal diseased and healthy gingival tissues.

Xie YF, Shu R, Jiang SY, Liu DL, Zhang XL.

Int J Oral Sci. 2011 Jul;3(3):125-34. doi: 10.4248/IJOS11046.


Association of microRNA-21 expression with its targets, PDCD4 and TIMP3, in pancreatic ductal adenocarcinoma.

Nagao Y, Hisaoka M, Matsuyama A, Kanemitsu S, Hamada T, Fukuyama T, Nakano R, Uchiyama A, Kawamoto M, Yamaguchi K, Hashimoto H.

Mod Pathol. 2012 Jan;25(1):112-21. doi: 10.1038/modpathol.2011.142. Epub 2011 Oct 7.


Deregulated expression of miR-21, miR-143 and miR-181a in non small cell lung cancer is related to clinicopathologic characteristics or patient prognosis.

Gao W, Yu Y, Cao H, Shen H, Li X, Pan S, Shu Y.

Biomed Pharmacother. 2010 Jul;64(6):399-408. doi: 10.1016/j.biopha.2010.01.018. Epub 2010 Feb 25.


miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3.

Li X, Zhang Y, Zhang H, Liu X, Gong T, Li M, Sun L, Ji G, Shi Y, Han Z, Han S, Nie Y, Chen X, Zhao Q, Ding J, Wu K, Daiming F.

Mol Cancer Res. 2011 Jul;9(7):824-33. doi: 10.1158/1541-7786.MCR-10-0529. Epub 2011 May 31.


Profiling of 95 microRNAs in pancreatic cancer cell lines and surgical specimens by real-time PCR analysis.

Zhang Y, Li M, Wang H, Fisher WE, Lin PH, Yao Q, Chen C.

World J Surg. 2009 Apr;33(4):698-709. doi: 10.1007/s00268-008-9833-0. Review.


microRNA expression profile in undifferentiated gastric cancer.

Katada T, Ishiguro H, Kuwabara Y, Kimura M, Mitui A, Mori Y, Ogawa R, Harata K, Fujii Y.

Int J Oncol. 2009 Feb;34(2):537-42.


Clinicopathological and prognostic significance of microRNA-107 and its relationship to DICER1 mRNA expression in gastric cancer.

Inoue T, Iinuma H, Ogawa E, Inaba T, Fukushima R.

Oncol Rep. 2012 Jun;27(6):1759-64. doi: 10.3892/or.2012.1709. Epub 2012 Mar 7.


miRNA signature associated with outcome of gastric cancer patients following chemotherapy.

Kim CH, Kim HK, Rettig RL, Kim J, Lee ET, Aprelikova O, Choi IJ, Munroe DJ, Green JE.

BMC Med Genomics. 2011 Nov 23;4:79. doi: 10.1186/1755-8794-4-79.


[Clinicopathological significance and function of miR-135b in the occurrence and development of gastric cancer].

Wang LP, Ma XQ, Cai JC.

Zhonghua Yi Xue Za Zhi. 2012 Dec 11;92(46):3269-73. Chinese.


Diagnostic and prognostic microRNAs in stage II colon cancer.

Schepeler T, Reinert JT, Ostenfeld MS, Christensen LL, Silahtaroglu AN, Dyrskjøt L, Wiuf C, Sørensen FJ, Kruhøffer M, Laurberg S, Kauppinen S, Ørntoft TF, Andersen CL.

Cancer Res. 2008 Aug 1;68(15):6416-24. doi: 10.1158/0008-5472.CAN-07-6110.


Comprehensive gene and microRNA expression profiling reveals the crucial role of hsa-let-7i and its target genes in colorectal cancer metastasis.

Zhang P, Ma Y, Wang F, Yang J, Liu Z, Peng J, Qin H.

Mol Biol Rep. 2012 Feb;39(2):1471-8. doi: 10.1007/s11033-011-0884-1. Epub 2011 May 29.


A microRNA profile comparison between thoracic aortic dissection and normal thoracic aorta indicates the potential role of microRNAs in contributing to thoracic aortic dissection pathogenesis.

Liao M, Zou S, Weng J, Hou L, Yang L, Zhao Z, Bao J, Jing Z.

J Vasc Surg. 2011 May;53(5):1341-1349.e3. doi: 10.1016/j.jvs.2010.11.113. Epub 2011 Feb 18.


Down-regulation of miR-125a-3p in human gastric cancer and its clinicopathological significance.

Hashiguchi Y, Nishida N, Mimori K, Sudo T, Tanaka F, Shibata K, Ishii H, Mochizuki H, Hase K, Doki Y, Mori M.

Int J Oncol. 2012 May;40(5):1477-82. doi: 10.3892/ijo.2012.1363. Epub 2012 Feb 9.


Microarray-based analysis: identification of hypoxia-regulated microRNAs in retinoblastoma cells.

Xu X, Jia R, Zhou Y, Song X, Wang J, Qian G, Ge S, Fan X.

Int J Oncol. 2011 May;38(5):1385-93. doi: 10.3892/ijo.2011.961. Epub 2011 Mar 3.


Expression levels of microRNA-192 and -215 in gastric carcinoma.

Chiang Y, Zhou X, Wang Z, Song Y, Liu Z, Zhao F, Zhu J, Xu H.

Pathol Oncol Res. 2012 Jul;18(3):585-91. doi: 10.1007/s12253-011-9480-x. Epub 2011 Dec 29.


Characterization of human platelet microRNA by quantitative PCR coupled with an annotation network for predicted target genes.

Osman A, Fälker K.

Platelets. 2011;22(6):433-41. doi: 10.3109/09537104.2011.560305. Epub 2011 Mar 25.


Differential microRNA expression and identification of putative miRNA targets and pathways in head and neck cancers.

Nurul-Syakima AM, Yoke-Kqueen C, Sabariah AR, Shiran MS, Singh A, Learn-Han L.

Int J Mol Med. 2011 Sep;28(3):327-36. doi: 10.3892/ijmm.2011.714. Epub 2011 Jun 1.

Items per page

Supplemental Content

Write to the Help Desk